Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

{{article.zuoZheEn}}

PDF(1393 KB)
PDF(1393 KB)
Front. Med. ›› 2022, Vol. 16 ›› Issue (1) : 93-101. DOI: 10.1007/s11684-021-0914-x
RESEARCH ARTICLE

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2022, 16(1): 93‒101 https://doi.org/10.1007/s11684-021-0914-x

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(1393 KB)

Accesses

Citations

Detail

Sections
Recommended

/